Open AccessThis article is
- freely available
Systemic Therapy of Non-Resectable Metastatic Melanoma
Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany
* Author to whom correspondence should be addressed.
Received: 8 March 2010; in revised form: 11 May 2010 / Accepted: 12 May 2010 / Published: 26 May 2010
Abstract: In advanced metastatic melanoma (non-resectable stage III/IV), the prognosis still remains poor, with median survival times between six and twelve months. Systemic therapeutic approaches for metastatic melanoma include chemotherapy, immunotherapy, immunochemotherapy, small molecules and targeted therapy. In this review, we will focus on the various treatment modalities as well as new agents used for targeted therapy.
Keywords: melanoma; metastatic; chemotherapy; targeted therapy; small molecules
Citations to this Article
Cite This Article
MDPI and ACS Style
Orouji, A.; Goerdt, S.; Utikal, J. Systemic Therapy of Non-Resectable Metastatic Melanoma. Cancers 2010, 2, 955-969.
Orouji A, Goerdt S, Utikal J. Systemic Therapy of Non-Resectable Metastatic Melanoma. Cancers. 2010; 2(2):955-969.
Orouji, Azadeh; Goerdt, Sergij; Utikal, Jochen. 2010. "Systemic Therapy of Non-Resectable Metastatic Melanoma." Cancers 2, no. 2: 955-969.